Evidence map›Paper›PMID 41294660›Full record

ArticleCurrent oncology (Toronto, Ont.)2025

Symptom Reporting Behaviors, Symptom Burden, and Quality of Life in Patients with Hormone Receptor-Positive Breast Cancer Undergoing Adjuvant Endocrine Therapy.

Ece Ulukal Karanci, Halil Göksel Güzel, Banu Öztürk

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ece Ulukal KaranciDepartment of Clinical Oncology, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0002-0930-1016
Halil Göksel GüzelDepartment of Clinical Oncology, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.
Banu ÖztürkDepartment of Clinical Oncology, Antalya Education and Research Hospital, University of Health Sciences, 07100 Antalya, Turkey.ORCID 0000-0003-0290-8787

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Agents, HormonalBreast NeoplasmsQuality of LifeAdultAgedAromatase InhibitorsChemotherapy, AdjuvantCross-Sectional StudiesFemaleHumansMiddle AgedSymptom BurdenTamoxifenAntineoplastic Agents, HormonalAromatase InhibitorsTamoxifenadjuvant endocrine therapyhormone receptor–positive breast cancerpatient-reported outcomesquality of lifesymptom burden

Identifiers

PMID41294660
PMCPMC12651645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.